Aemetis, Inc. (NASDAQ:AMTX) Given Average Recommendation of “Moderate Buy” by Brokerages

Aemetis, Inc. (NASDAQ:AMTX) has been assigned a consensus rating of “Moderate Buy” from the five brokerages that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $12.95.

A number of equities analysts recently issued reports on AMTX shares. StockNews.com upgraded shares of Aemetis to a “sell” rating in a research report on Friday. HC Wainwright reiterated a “buy” rating and issued a $28.00 price target on shares of Aemetis in a research note on Monday, December 23rd.

Aemetis Stock Performance

Aemetis stock opened at $2.97 on Monday. Aemetis has a 52 week low of $2.10 and a 52 week high of $7.03. The stock has a market capitalization of $147.71 million, a P/E ratio of -1.31 and a beta of 1.47. The stock has a fifty day moving average of $3.27 and a 200-day moving average of $2.97.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping the consensus estimate of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same period in the previous year, the firm posted ($0.59) EPS. On average, research analysts forecast that Aemetis will post -2.02 earnings per share for the current year.

Hedge Funds Weigh In On Aemetis

Several large investors have recently modified their holdings of AMTX. FMR LLC increased its holdings in Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after purchasing an additional 9,137 shares during the period. Hutchinson Capital Management CA acquired a new stake in shares of Aemetis in the second quarter valued at about $70,000. Barclays PLC raised its position in shares of Aemetis by 274.6% during the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after acquiring an additional 34,816 shares during the last quarter. Rhumbline Advisers lifted its stake in shares of Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after acquiring an additional 50,528 shares during the period. Finally, Wellington Management Group LLP bought a new stake in Aemetis in the third quarter valued at approximately $177,000. Institutional investors own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.